From Months to Minutes: Can AI Really Transform Regulatory Submissions? For regulatory professionals, the idea of cutting hundreds of hours of painstaking work down to
We know that migrating from complex, entrenched legacy systems can be daunting – especially when you’re managing large volumes of data and critical processes. That’s
Loba biotech GmbH, a wholly owned GMP manufacturing subsidiary of pharmaand GmbH (pharma&), has chosen Generis’ CARA Life Sciences Platform to launch its digital Quality
AI-powered CARA Platform and new Starter Pack Model fuel rapid expansion across regulated sectors LONDON, UK – Generis, creator of the CARA Platform and CARA
Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences
Kwizda Pharma, a division of Kwizda Holding GmbH and a leader in the Austrian healthcare market, has selected the CARA Life Sciences Platform from Generis,
© Copyright 2002-2026, Generis Enterprise Technology Limited, all rights reserved
